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A B S T R A C T   
Declining attendance in the Dutch cervical cancer screening programme was recently observed, coinciding with 
preparations for implementing primary hrHPV-based screening, which was implemented in January 2017. We 
aimed to investigate which factors were related to decreased attendance. We conducted a population-based 
cohort study including all women aged 30 to 60 years who were eligible for screening between 2014 and 
2018. Attendance was defined as participation in the screening programme within 15 months of the start of the 
invitation-eligible year. We used data from the Dutch pathology archive (PALGA) linked with data from Statistics 
Netherlands to investigate population characteristics (position in the household, household income, socio- 
economic status, number of people in the household, migration background, age) and data from the five 
Dutch screening organisations (SO) to investigate the effect of cessing self-inviting GP’s (‘inviting organisation’). 
SO’s were termed SO 1 to 5. Higher attendance rates were observed in women who were employed (60.8%), 
married (62.9%), Dutch (61.2%), in the highest income bracket (63.4%), living in households with four persons 
(65.3%) and women who were invited by their GP (69.8%). Differences in personal characteristics did not 
explain the decline in attendance rates. By adjusting for whether the GP or the SO sent the invitation, the dif-
ferences in attendance rates between 2014 and 2015 and 2016 and between 2014 and 2015 and 2017–2018 were 
explained in some screening organisations. Removing the possibility for GPs to send invitations explains some of 
the decline in participation, although this did not account for the total change in attendance.   
1. Introduction 
Organised cancer screening programmes are only able to provide 
maximum benefit to the population if attendance is high. Women who 
do not participate in cervical cancer screening make up the majority of 
cervical cancer diagnoses (Bos et al., 2006). Therefore, monitoring the 
attendance rate is an important part of quality assurance in organised 
screening programmes. 
In the Netherlands, participation in the cervical cancer screening 
programme had been relatively stable. Over the period 2012 to 2015, 
attendance rates ranged between 64.4% and 66.2% (Erasmus MC & 
PALGA, 2017). In January 2017, a new high-risk human papillomavirus 
(hrHPV) based screening programme was introduced nationwide. The 
implementation took place over the first quarter of 2017, however, some 
changes were already made in 2016 (e.g. accelerated invitations, re-
minders were stopped earlier, women could only participate until 1 
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December 2016, GP invitations were stopped). Given the changes in 
2016, a lower participation rate was not surprising (60.3%) (Erasmus 
MC & PALGA, 2017), however following the first year of the new pro-
gramme, attendance declined further (2017: 57.4%) (Erasmus MC & 
PALGA, 2018). Screening organisations anticipated some catch up 
attendance because of the transition. However, in 2018, the attendance 
rate remained below 60% (Netherlands Cancer Registry, 2019). Lower 
participation in the new programme was unexpected, as hrHPV self- 
sampling is now offered as an alternative screening method for 
women who did not feel comfortable with being screened by their 
general practitioner (GP). Self-sampling has been shown to be a prom-
ising strategy to encourage participation amongst non-responders to 
regular screening programme invitations (Gok et al., 2010; Broberg 
et al., 2014). 
When the new screening programme was introduced, day-to-day 
management was streamlined. All five screening organisations in the 
Netherlands (SO; responsible for the implementation of the programme 
across five geographical regions) implemented standardised invitation 
and reminder policies, after which all invitations were sent by the SO’s 
following the birthdate of each eligible woman. Previously, some gen-
eral practices sent invitations to their patients on behalf of the SO’s and 
the time of the year when women were invited varied. 
Changes to both the primary test and policies seem to have affected 
attendance, however it is unclear what is driving the change. We aimed 
to investigate this by analysing attendance rates and attenders in the 
Dutch cervical screening programme leading up to, during, and after the 
implementation of the new hrHPV-based screening programme. Spe-
cifically, we aimed to investigate what factors influence attendance, and 
what factors have influenced the decrease in attendance between 2014 
and 2018. 
2. Materials and methods 
2.1. Setting 
Organised cervical cancer screening has been offered in the 
Netherlands for more than thirty years. Since 1996, women aged 30 to 
60 years have been invited to participate every five years. Before 2017, 
women were screened using cervical cytology. Starting in 2017, hrHPV- 
based primary screening was implemented, including the option of self- 
sampling. 
2.2. Participants 
All women aged 30 to 60 years who are living in the Netherlands are 
invited for screening every five years. Women who were eligible to 
receive an invitation for screening in years 2014 to 2018 based on their 
year of birth were included in our study (Table A1). 
2.3. Data sources 
We used two datasets that each combined two data sources; one 
dataset containing information about population characteristics and one 
dataset containing information about organisational factors. Detailed 
information about the contents of each dataset is outlined below. For 
legal and practical reasons, linkage between population characteristics 
data and organisational factors data was not possible. Therefore, we 
conducted separate, parallel analyses with the two datasets. 
2.3.1. Population characteristics 
To investigate population characteristics, we linked data from the 
nationwide network of cyto- and histopathology (PALGA) with socio- 
economic information from Statistics Netherlands (Centraal Bureau 
voor de Statistiek, acronym CBS). This dataset is further referred to as 
PALGA/CBS (Fig. 1). PALGA has complete coverage of all pathology 
labs in the Netherlands (Casparie et al., 2007). We selected primary 
screening tests of women who participated in 2014–2018. Screening 
tests that were recorded within 15 months of the start of year of invi-
tation eligibility were included (e.g. for women eligible for invitation in 
2014, smears recorded between 1 January 2014 and 31 March 2015 
were included). We requested that CBS select data for women in the 
target population for screening (Table A1). Deterministic linkage was 
used. 99.3% of PALGA records could be matched with a CBS identifier. 
The linkage rate between the two datasets was 57.4%, because non- 
attenders had no information in PALGA. 
NB. Each cell represents information from one unique woman invited 
for screening. Orange box contains the party that was responsible for 
data linkage. Yellow rows represent cases that are defined as ‘non- 
attenders’. 
Information about personal characteristics (migration background, 
income, socioeconomic status and household composition) was pro-
vided for each year (2014 to 2018) that a woman had data recorded in 
CBS; therefore, each woman in the dataset had a maximum of five values 
for each variable. We assigned each record to a screening invitation year 
Fig. 1. Process to create PALGA/CBS dataset.  
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(2014–2018) based on their age on 1 January (i.e. a woman was allo-
cated to 2014 if her age was 29, 34, 39, 44, 49, 54 or 59 years on 1 
January 2014). Based on the invitation year, we selected values for each 
CBS variable for each woman. 
2.3.2. Organisational factors 
In order to classify organisational factors, we obtained data from the 
five SO’s about all invitations sent during the period 2014–2018. This 
dataset was the result of merging two registries; one used in the new 
hrHPV-based programme (‘ScreenIT’) and one used in the old cytology- 
based programme (‘CIS’). This dataset is further referred to as ScreenIT/ 
CIS (Fig. 2). This dataset included information about date of invitation, 
participation and inviting organisation (SO or GP). 
NB. Each cell represents information from one unique woman invited 
for screening. Orange box contains the party that was responsible for 
data linkage. Yellow rows represent cases that are defined as ‘non- 
attenders’. 
2.4. Data definitions 
We defined attenders as women who had a screening test within 15 
months of the beginning of the year of invitation (e.g. for women eligible 
for invitation in 2018, attenders had screens recorded between 1 
January 2018 and 31 March 2019). Non-attenders were women without 
a screening test recorded. In practice, this was done slightly differently 
in each dataset. In PALGA/CBS data, non-attenders were defined as 
women who are in the target population (i.e. in CBS) but did not have a 
matched link between PALGA and CBS (i.e. not in PALGA; Fig. 1). In 
ScreenIT/CIS, non-attenders were all women who were invited but did 
not have a screen recorded within 15 months of the start of the invitation 
year. There were a higher number of attenders in ScreenIT, but fewer 
non-attenders compared to PALGA/CBS (Fig. A1). 
In both datasets, we combined invitation year into three categories; 
the old cytology-based programme (2014–2015), the transition year 
(2016) and the new hrHPV-based programme (2017–2018). 
We named the five SO’s SO 1 to 5 in order to pseudonymise them. 
The SO that a woman is allocated to is based on the council area in which 
the woman lives. SO is automatically recorded in PALGA and ScreenIT/ 
CIS. For non-attenders in PALGA/CBS, there was no SO region infor-
mation. We had information about city council area for each woman 
from CBS and a concordance between SO regions and city council areas 
from PALGA. Using this information, we were able to allocate non- 
attenders to a SO. 
2.4.1. Population characteristics 
Socio-economic status was determined by CBS based on income 
source. If a person has multiple sources of income in a particular year, 
the income source that contributes the largest amount is used to classify 
this variable into one of 14 categories. We grouped this variable into 
broader categories: employed; not employed, social welfare; not 
employed, in education; no income. 
Position in the household was determined by CBS by comparing each 
household member to the main breadwinner and was classified as: 
breadwinner without partner; breadwinner with partner; married part-
ner; unmarried partner; adult child; other household member. 
We classified the number of people living in a household into six 
categories: one; two; three; four; five; six or more. 
Standardised household income percentile was calculated by CBS for 
private households, excluding student houses. We grouped this variable 
into four categories: 1–24%; 25–49%; 50– 74%; 75–100%. 
For migration background, we combined CBS variables ‘migration 
generation’ and ‘country of origin’. Migration generation was deter-
mined by country of birth of women themselves and their parents; a 
person was classified as Dutch if both parents were born in the 
Netherlands, a first generation migrant was a person who was born 
abroad and has at least one parent who was also born abroad and a 
second generation migrant was a person who was born in the 
Netherlands with a least one parent born abroad. Country of origin was 
determined by the country of birth of either the woman’s parents or 
themselves. Country of origin was classified by CBS into ‘Western’ 
(Europe excluding Turkey, North America, Oceania, Indonesia and 
Japan) and ‘non-Western’ (Africa, Latin America and Asia [excluding 
Indonesia and Japan] and Turkey) (Statistics Netherlands (CBS), 2020). 
Based on these two variables, we categorised women into the following 
groups: Dutch; non-Western, first generation; non-Western, second 
generation; Western, first generation; Western, second generation. 
2.4.2. Organisational factors 
Inviting organisation was automatically recorded in ScreenIT/CIS. 
This could be either the SO or the woman’s registered general practice. 
Fig. 2. Process to create ScreenIT/CIS dataset.  
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GPs could only send screening invitations in the old cytology-based 
programme. This practice stopped in 2016. Table A2 contains infor-
mation on the proportion of invitations sent by self-inviting GP 
practices. 
2.5. Statistical analysis 
Data management and analysis was conducted using IBM SPSS Sta-
tistics for Windows v25 (Armonk, NY, IBM Corporation) and RStudio 
(using R v.3.6.2; Boston, MA). Because our endpoint, attendance, has 
high prevalence in our population (~60%), odds ratios would have been 
overinflated (Zhang and Yu, 1998). Due to this, we performed multi-
variate Poisson regression analysis. To control for the fact that invitation 
and reminder policies were directly related to SO between 2014 and 
2016 (see Table A2), we calculated one model per SO. 
2.5.1. Population characteristics 
We used R package ‘mice’ to impute missing values in ‘standardised 
income percentile’ using five iterations (van Buuren and Groothuis- 
Oudshoorn, 2011). We performed pooled multivariate Poisson regres-
sion analysis per SO to investigate which personal characteristics 
impacted the decrease in attendance between 2014 and 2018. 
2.5.2. Organisational factors 
We used IBM SPSS Statistics for Windows v25 to calculate multi-
variate Poisson regression per SO to investigate whether the inviting 
organisation impacted the decrease in attendance between 2014 and 
2018. 
2.6. Data availability 
Results of this study are based on our own calculations on publically 
available data from CBS (dataset name: “Erasmus_MC_B-
VO_2014_2018_V1_DEF.sav”). This is available upon request to CBS 
(microdata@cbs.nl). Data from PALGA is available upon request after 
approval by the Scientific Committee of PALGA. Data from ScreenIT/CIS 
is available upon request from the Dutch SO’s. 
2.7. Ethical approval 
The Medical Ethics Committee of Erasmus MC University Medical 
Center reviewed the protocol for the linkage of PALGA with CBS and 
confirmed that it was not subject to the Medical Research Involving 
Human Subjects Act in the Netherlands and, therefore, exempt from 
ethics approval (MEC-2019-0672). All data owners gave approval for 
the use of their data for the purposes of this study in compliance with 
GDPR. 
3. Results 
3.1. Attendance trends and descriptives 
Table 1 show descriptives by SO for personal characteristics by 
attendance status. Compared to non-attenders, the cohort of attenders 
had a higher proportion of women who were Dutch (from 73% in SO 4 to 
90% in SO 2), were employed (from 76% in SO 4 to 79% in SO 1) and 
were in the highest income bracket (from 29% in SO 2 to 41% in SO 1) 
Fig. 3 shows attendance rates by SO, year of eligibility for invitation 
and data source. For all SO’s, there has been a decline in participation in 
the screening programme from 2014 to 2015 to 2017–2018. In each SO, 
the attendance rates are lower calculated in the PALGA/CBS dataset 
than in the ScreenIT/CIS data. The largest drop in attendance rate was 
seen in SO 3, dropping from 67.0% in 2014–2015 to 58.6% in 
2017–2018 (using PALGA/CBS data). Calculating attendance rates in 
ScreenIT/CIS resulted in higher attendance in all SO’s across all years, 
mainly due to a lower number of non-attenders in ScreenIT/CIS 
(Fig. A1). 
Supplementary Figs. A2 to A8 show attendance rates by personal 
characteristics and inviting organisation. The highest attendance rates 
were amongst women who were employed (Fig. A4; 60.8%), married 
(Fig. A6; 62.9%), Dutch (Fig. A7; 61.2%), in the highest income bracket 
(Fig. A5; 63.4%) or living in households with four persons (Fig. A3; 
65.3%). Attendance rates were significantly higher amongst women 
who were invited by their GP than women invited by their SO (Fig. A8; 
69.8%). 
3.2. Factors affecting attendance 
3.2.1. Population characteristics (PALGA/CBS data) 
Table 2 shows the results of Poisson regression analysis for atten-
dance using PALGA/CBS data, by year of eligibility for invitation, un-
adjusted and adjusted for population characteristics. In the unadjusted 
models, the relative risk (RR) of participation in the screening pro-
gramme was significantly lower in all five SO’s in 2016 and 2017–2018 
compared with 2014–2015. Following adjustment, there was almost no 
change in the RR of participation for any of the five SO’s; that is, all RRs 
were still significantly lower in 2016 and 2017–2018 compared with 
2014–2015. RRs of attendance compared to 2014–2015 were lowest in 
SO 3 (2016: RR 0.909 (95% CI: 0.901–0.917); 2017–2018: RR 0.876 
(95% CI: 0.870–0.883)). 
Supplementary Tables A3 to A7 show the RR of attendance for each 
of the population characteristic included in our analysis. Factors 
affecting attendance followed similar patterns across all SO’s. Women 
aged 35 years and older had a significantly higher RR of attendance than 
women aged 30 years. Compared to women who were Dutch, all other 
migration background groups had a lower RR of attendance. Following 
adjustment, only married women had a significantly higher RR of 
attendance compared to women who were the main breadwinner 
without a partner, with the exception of SO’s 1 and 5, in which the 
increased risk was non-significant. 
3.2.2. Organisational factors (ScreenIT/CIS) 
Table 3 shows the results of Poisson regression analysis for atten-
dance using ScreenIT/CIS data, by year of eligibility for invitation, un-
adjusted and adjusted for inviting organisation. In the unadjusted 
models, the RR of participation in the screening programme was 
significantly lower in all five SO’s in 2016 and 2017–2018 compared 
with 2014–2015. Following adjustment for inviting organisation (either 
SO or GP), there was no significant difference between the RR of 
participation in SO 1 for participation in 2017–2018 (RR 0.997 (95% CI: 
0.990–1.003)) and in SO 4 for participation in 2016 (RR 0.998 (95% CI: 
0.990–1.007)). Following adjustment, the RR of participation was 
higher in 2016 compared to 2014–2015 in both SO 1 (RR 1.028 (95% CI: 
1.020–1.035)) and SO 5 (RR 1.034 (95% CI: 1.026–1.043)). 
4. Discussion 
Our aim was to investigate which factors influence attendance, and 
which factors have influenced the decrease in attendance between 2014 
and 2018. Cessing the use of self-inviting general practices appears to 
have had an impact on attendance. Following adjustment for inviting 
organisation, RRs moved closer to 1 in all SO’s. The importance of GP 
invitations in the Dutch screening programme has been previously 
observed; Tacken and colleagues found that the odds of attendance in a 
Dutch population increased when invitations and reminders were sent 
by a woman’s GP (OR compared to SO invitation: 1.73 (95% CI: 
1.15–2.60)) (Tacken et al., 2007). Greater involvement by GPs in the 
cervical screening programme was previously shown to increase atten-
dance rates (Kant et al., 1997) and compliance with follow-up advice 
(Palm et al., 1997). The effect of having an invitation sent by the GP has 
been shown to have a greater impact in groups that have lower atten-
dance rates, such as young women, women with a migration background 




Distribution of co-variates by attendance status and screening organisations, the Netherlands, 2014–2018.   
SO 1 SO 2 SO 3 SO 4 SO 5  
Attenders Non 
-attenders 
p Attenders Non 
-attenders 
p Attenders Non 
-attenders 
p Attenders Non 
-attenders 




N in PALGA/CBS 576,273 471,169  220,782 160,713  450,647 270,793  490,133 423,928  489,713 338,025  
N in ScreenIT/CIS 596,872 458,395  226,592 141,533  453,994 248,417  511,482 399,388  502,588 297,002  
Inviting organisation* 
Screening organisation 85.4% 90.4% <0.01 97.7% 98.7% <0.01 71.3% 81.9% <0.01 80.6% 87.7% <0.01 83.9% 88.3% <0.01 
Self-inviting GP practice 14.6% 9.6% 2.3% 1.3% 28.7% 18.1% 19.4% 12.3% 16.1% 11.7% 
Invitation age                
30 years 11.9% 17.5% <0.01 10.1% 14.7% <0.01 10.5% 15.0% <0.01 11.2% 17.0% <0.01 10.1% 15.0% <0.01 
35 years 12.3% 15.4% 11.3% 12.5% 11.8% 12.8% 12.4% 14.7% 11.4% 12.6% 
40 years 13.8% 12.8% 12.9% 11.6% 13.2% 11.8% 13.6% 12.7% 12.8% 11.2% 
45 years 16.8% 13.9% 16.6% 14.6% 16.8% 14.2% 16.6% 14.0% 16.3% 13.9% 
50 years 16.8% 13.8% 17.4% 15.2% 17.5% 14.8% 17.0% 13.7% 17.7% 15.2% 
55 years 15.6% 13.5% 16.9% 15.4% 16.4% 15.5% 16.0% 14.0% 17.3% 15.8% 
60 years 12.8% 13.1% 14.8% 16.0% 13.8% 15.9% 13.3% 13.8% 14.3% 16.3% 
Migration background 
Dutch 75.3% 60.7% <0.01 90.1% 85.7% <0.01 86.6% 79.6% <0.01 73.4% 58.7% <0.01 84.3% 74.0% <0.01 
Non-western, first generation 11.0% 18.6% 3.3% 5.3% 5.2% 8.2% 13.1% 20.0% 5.5% 9.0% 
Non-western, second 
generation 
2.8% 5.3% 0.6% 1.0% 1.0% 2.1% 2.8% 5.6% 1.0% 2.2% 
Western, first generation 5.4% 9.9% 2.8% 4.3% 3.0% 5.2% 5.6% 10.6% 4.4% 9.1% 
Western, second generation 5.5% 5.5% 3.2% 3.7% 4.2% 4.9% 5.0% 5.1% 4.9% 5.8% 
Socio-economic status (based on income source) 
Employed 78.5% 68.1% <0.01 76.6% 66.3% <0.01 77.8% 67.3% <0.01 76.3% 65.2% <0.01 77.7% 66.8% <0.01 
Not employed, social welfare 13.7% 20.4% 14.0% 22.2% 13.2% 21.2% 13.8% 21.2% 13.6% 21.8% 
Not employed, in education 0.4% 0.7% 0.4% 0.8% 0.3% 0.5% 0.4% 0.8% 0.2% 0.4% 
No income 7.4% 10.8% 9.0% 10.8% 8.8% 11.0% 9.5% 12.7% 8.5% 11.0% 
Number of people in the household 
One person 14.0% 20.1% <0.01 10.7% 17.4% <0.01 9.4% 16.9% <0.01 12.2% 19.1% <0.01 9.6% 16.3% <0.01 
Two people 28.7% 29.9%  30.6% 31.9%  28.1% 30.8%  29.2% 30.6%  30.2% 33.3%  
Three people 20.8% 20.4%  20.3% 20.1%  20.7% 20.3%  22.0% 21.0%  21.8% 21.5%  
Four people 26.4% 19.2%  27.4% 20.3%  29.0% 20.5%  26.0% 18.7%  28.5% 19.9%  
Five people 7.9% 7.0%  8.7% 7.3%  9.8% 7.8%  8.0% 7.0%  8.0% 6.4%  
Six or more people 2.1% 3.5%  2.2% 3.0%  3.0% 3.7%  2.5% 3.7%  1.9% 2.6%  
Standardised income percentile 
1–24% 14.2% 23.5% <0.01 16.9% 25.3% <0.01 14.5% 22.8% <0.01 15.7% 25.8% <0.01 13.6% 22.6% <0.01 
25–49% 17.6% 19.0%  23.4% 23.7%  21.6% 22.0%  18.3% 19.7%  19.4% 20.8%  
50–74% 26.8% 23.0%  30.0% 25.4%  30.1% 25.8%  27.0% 23.0%  29.9% 25.7%  
75–100% 40.9% 31.5%  29.1% 22.9%  33.2% 26.5%  38.4% 28.4%  36.6% 28.2%  
Missing 0.6% 2.9%  0.6% 2.7%  0.5% 2.9%  0.6% 3.2%  0.5% 2.8%  
Position in the household 
Breadwinner without partner 24.5% 32.0% <0.01 19.2% 27.4% <0.01 17.1% 25.9% <0.01 22.9% 31.9% <0.01 17.8% 26.2% <0.01 
Breadwinner with partner 15.4% 14.6%  14.9% 14.0%  13.2% 12.8%  13.3% 13.0%  13.0% 12.9%  
Married partner 44.7% 35.9%  51.3% 41.9%  55.5% 44.7%  50.1% 38.9%  53.9% 43.2%  
Unmarried partner 13.7% 13.4%  13.3% 13.7%  12.5% 12.7%  12.0% 12.0%  13.5% 13.8%  
Adult child 0.9% 2.2%  0.7% 1.8%  0.9% 2.4%  0.9% 2.2%  1.0% 2.3%  
Other household member 0.9% 2.1%  0.6% 1.3%  0.8% 1.6%  0.8% 1.9%  0.8% 1.6%  
*Data from ScreenIT/CIS. 
NB: Proportions are rounded to one decimal place and, therefore, may not sum to 100%. 
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and women with a lower SES (de Nooijer et al., 2005). The Health 
Council of the Netherlands advised in 2011, based on findings from an 
expert committee that included GPs, that more GPs should be involved 
in the invitation process as this is the most effective method for pro-
moting attendance, especially in particular population subgroups 
(Health Council of the Netherlands, 2011). The more personal approach 
of being contacted by a trusted healthcare provider, rather than a gov-
ernment organisation, may have encouraged some women to partici-
pate. Re-instating GP invitations may have a positive impact on future 
attendance. 
Results of our study show that, although there are differences be-
tween the personal characteristics of attenders and non-attenders, these 
differences do not explain the decline in attendance. Like in other 
Fig. 3. Attendance rates by screening organisation, year of eligibility for invitation and data source, the Netherlands, 2014–2018.  
Table 2 
Results of Poisson regression analysis for attendance using PALGA/CBS data, by 
year of eligibility for invitation, unadjusted and adjusted for population char-
acteristics, the Netherlands, 2014– 2018.   
Unadjusted 
model 
Adjusted models  
Model 11 Model 22 Model 33 Model 44  
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) 
SO 1     

















SO 2     
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SO 5     

















RR: relative risk; CI: confidence interval. 
NB: Estimates are rounded to three decimal places. 
1 Unadjusted model. Year of eligibility for invitation only. 
2 Adjusted model. Year of eligibility for invitation and migration background. 
3 Adjusted model. Year of eligibility for invitation, migration background, 
socio-economic status (based on income source), number of persons in house-
hold, position in household and standardised household income percentile. 
4 Adjusted model. Year of eligibility for invitation, migration background, 
socio-economic status (based on income source), number of persons in house-
hold, position in household, standardised household income percentile and age. 
Table 3 
Results of Poisson regression analysis for attendance using ScreenIT/CIS data, by 
year of eligibility for invitation, unadjusted and adjusted for inviting organisa-
tion the Netherlands, 2014–2018.   
Unadjusted model Adjusted model  
Model 11 Model 22  
RR (95% CI) RR (95% CI) 
SO 1   
2014–2015 1.000 (ref) 1.000 (ref) 
2016 0.964 (0.958–0.971)* 1.028 (1.020–1.035)* 
2017–2018 0.935 (0.930–0.941)* 0.997 (0.990–1.003) 
SO 2   
2014–2015 1.000 (ref) 1.000 (ref) 
2016 0.963 (0.953–0.974)* 0.971 (0.960–0.982)* 
2017–2018 0.921 (0.913–0.930)* 0.928 (0.920–0.937)* 
SO 3   
2014–2015 1.000 (ref) 1.000 (ref) 
2016 0.881 (0.874–0.888)* 0.990 (0.980–1.000)* 
2017–2018 0.876 (0.870–0.882)* 0.984 (0.975–0.993)* 
SO 4   
2014–2015 1.000 (ref) 1.000 (ref) 
2016 0.919 (0.912–0.925)* 0.998 (0.990–1.007) 
2017–2018 0.887 (0.881–0.892)* 0.964 (0.957–0.971)* 
SO 5   
2014–2015 1.000 (ref) 1.000 (ref) 
2016 0.991 (0.984–0.998)* 1.034 (1.026–1.043)* 
2017–2018 0.921 (0.915–0.927)* 0.961 (0.954–0.968)* 
*p < 0.05. 
NB: Estimates are rounded to three decimal places. 
1 Unadjusted model. Year of eligibility for invitation only. 
2 Adjusted model. Year of eligibility for invitation and inviting organisation. 
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organised European screening programmes, attendance in the Dutch 
programme was lower amongst women with a migration background 
(Leinonen et al., 2017a, 2017b; Harder et al., 2018; Kristensson et al., 
2014), women in lower income brackets (Harder et al., 2018; Broberg 
et al., 2018) and women who live alone or are not married (Kristensson 
et al., 2014; Broberg et al., 2018; Virtanen et al., 2015). Addressing 
disparities in participation across population subgroups is necessary to 
ensure that screening benefits all eligible women. 
Self-sampling has been shown to reduce non-attendance, however, 
lower participation in the Dutch programme comes in spite of the 
introduction of self-sampling. This may, in part, be due to the fact that 
women in the Dutch programme need to order their self-sampling kit via 
a web portal. Studies have found that sending self-sampling kits directly 
to non-responders increased participation (Gok et al., 2010; Elfstrom 
et al., 2019; Giorgi Rossi et al., 2015) and that sending self-sampling kits 
directly to women has been shown to be more effective at increasing 
participation than ‘opt-in’ strategies (Arbyn et al., 2018; Verdoodt et al., 
2015; Tranberg et al., 2018). Having to actively obtain a kit has shown 
mixed results; some studies show that offering the opportunity to order 
or collect a self-sampling kit results in higher participation (Broberg 
et al., 2014; Elfstrom et al., 2019) and some studies show no increase 
compared to standard procedures. (Giorgi Rossi et al., 2015, 2011) 
Making it easier to order the kit or sending the kit directly to non- 
responders may improve uptake in the Dutch programme. However, a 
Danish study found that not all non-attenders respond equally to the 
offer of self-sampling; non-attending women from lower socio-economic 
status, with a migration background and who found cervical cancer 
screening irrelevant to them were all less likely to use self-sampling 
(Harder et al., 2018). 
Despite the difference made to RRs by adjusting for inviting orga-
nisation, estimates in all but one SO remained significantly lower in 
2017–2018. There are some additional organisational factors that we 
were unable to control for that may also have impacted attendance. In 
the old cytology-based programme, smears could be taken by GPs 
without the invitation letter, meaning that women could be screened by 
their GP even if they had come to the clinic for another reason; a screen 
within the programme was registered if it was specified as such on the 
laboratory form. In the new hrHPV-based programme, screening within 
the programme is only possible if a women brings her invitation letter to 
the GP, as it contains personalised stickers that need to be stuck to the 
sample vial for lab processing. It could be that more women were 
screened in the old programme because it was simply easier to have a 
screen registered as being taken in the programme. The hrHPV test itself 
may also be a barrier for some women to participate. However, several 
studies on regional implementation of primary HPV screening have not 
shown lower attendance in comparison to cytology-based screening 
(Thomsen et al., 2020; Passamonti et al., 2017; Pasquale et al., 2015; 
Veijalainen et al., 2019), suggesting that the test itself may not be the 
reason for decreased attendance. 
Our study has several strengths. We have a unique dataset with in-
formation about the personal characteristics of both attenders and non- 
attenders to the screening programme. Our datasets were large and had 
population-wide coverage. Because of this, we can be certain that our 
statistical estimates are robust. Our study is also the first to show 
attendance behaviours in a nationally implemented hrHPV-based cer-
vical screening programme. 
Our study also has some limitations. Some non-attenders would be 
ineligible for screening due to hysterectomy. While hysterectomy in-
formation is available in ScreenIT/CIS, we did not use this for adjust-
ment as it is incomplete (only available if a woman reports this to the 
SO). We were unable to use hysterectomy data to adjust the eligible 
population in PALGA/CBS due to left-censoring in our PALGA extract 
and the linkage protocol used (i.e. we only linked primary screening 
programme screens, not histological examinations). If adjustment was 
possible, attendance would be slightly higher in all years (due to a 
smaller denominator). However, it is unlikely that ineligibility due to 
hysterectomy has changed over our study period, so we expect this has 
not impacted our results. The difference between attendance rates be-
tween ScreenIT/CIS and PALGA/CBS were due to lower numbers of non- 
attenders and overall records in ScreenIT/CIS (Fig. A1). The exact rea-
sons for this difference are unclear, but may be due to a lower number of 
invitations sent than women in the population, due to opt-outs and some 
women not being at risk, i.e. having no cervix. Socioeconomic status is a 
combination of factors related to income, education and occupation 
(Baker, 2014), however, we did not include education level as a co- 
variate. Educational status data was only complete from registry data 
for a selection of women in our cohort. As such, we chose not to include 
this information in our study. 
5. Conclusion 
Removing the possibility for GPs to send invitations explains a large 
part of the decline in participation in the Dutch cervical cancer screening 
programme, although this did not account for the total change in 
attendance. While certain population groups had lower attendance 
rates, personal characteristics of attenders and non-attenders do not 
explain the decline in participation. Other factors, such as necessitating 
the invitation letter be taken to the screening appointment or attitudes 
to hrHPV screening, should be investigated as additional causes for 
reduced attendance. GP invitations should be reintroduced to increase 
attendance. 
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